Monday, Sep 28, 2026 · SEC filings
What the smart money revealed on Sep 28
301 insider filings came in. We hid 35 planned (10b5-1) sellers and 218 people whose filings were routine, like grants and tax withholding.
Inhibrx Biosciences (INBX) CEO Mark Lappe bought $999K
10,000 shares on the open market. Not a grant or an option exercise.
Infinity Natural Resources (INR) EVP and CFO Cary Baetz bought $300K
22,316 shares on the open market. Not a grant or an option exercise.
Angel Oak Mortgage REIT (AOMR) Director Michael Fierman bought $290K
38,726 shares on the open market. Not a grant or an option exercise.
Damora Therapeutics (DMRA) Director Jennifer Jarrett bought $253K
12,500 shares on the open market. Not a grant or an option exercise.
Everpure (P) Chief Product Officer Ajay Singh sold $5.33M
Not marked as a planned 10b5-1 sale. Sold 13% of the shares they held directly. Still holds 288,362 shares.
Qfin (QFIN) Director Andrew Yan sold $4.89M
Not marked as a planned 10b5-1 sale. Sold every share held directly.
Rent the Runway (RENT) Director Dhiren Fonseca sold $128K
Not marked as a planned 10b5-1 sale. Sold every share held directly.
13F season
Holdings as of Jun 30, 2026 are due Aug 14
8,899 funds have filed so far. 8,900 filed for the quarter before.
Biggest real insider buys this week
Open-market buys by officers and directors, filed in the 7 days up to Sep 28.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.